Benbow M., Iosson, G. A clinical evaluation of UrgoTul to treat acute and chronic wounds. Br J Nurs 2004; 13: 2, 105–109. Bernard FX et al. Effets d’un pansement lipidocolloïde sur la production de matrice extracellulaire. Journal des Plaies et Cicatrisations, 2007 (study conducted on Urgotul). Single Use Forceps Griprite Forceps Artery Forceps Dissecting Forceps Dressing Forceps Tissue Forceps Sponge Holders Forceps Splinter Forceps More....

Urgotul: a novel non-adherent lipidocolloid dressing - PubMed Urgotul: a novel non-adherent lipidocolloid dressing - PubMed

Pharmaceuticals - R Pharmaceuticals - S Pharmaceuticals - T Pharmaceuticals - U Pharmaceuticals - V Pharmaceuticals - W Pharmaceuticals - X Pharmaceuticals - Y Pharmaceuticals - ZMeaume S, Truchetet F, Cambazard F et al. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair Regen. 2012; 20: 4, 500–511.

UrgoTul™ Ag - WoundSource UrgoTul™ Ag - WoundSource

Clean the wound according to local protocol, then rinse with normal saline. If an antiseptic has previously been used, rinse the wound carefully with normal saline before applying UrgoCleanIn the absence of clinical data relative to uncomplicated acute wounds and in the context of Epidermolysis Bullosa, irrespective of duration, the use of UrgoStart is not recommended. UrgoClean can be cut using sterile scissors to adjust the size of the dressing to the wound if necessary

UrgoTul Range Urgo Medical | UrgoTul Range

If clinical signs of local infection are noted, treatment can be changed to an antibacterial dressing dependent on clinical judgement. UrgoClean is indicated for the treatment of exuding wounds in the desloughing phase (chronic wounds and acute wounds). Ease of dressing removal. Hundred percent of the Urgotul ™‐dressed wounds were reported as ‘very easy’ to change versus 87% and 13% reported as ‘easy’ and ‘difficult’ to change respectively in the TG‐dressed wounds. Ultra-flexible lipido-colloid dressing: Polyester mesh impregnated with TLC: hydocolloid and pharmaceutical grade jelly particles UrgoTul should be changed every 2 to 4 days depending on the type of wound and its clinical condition. UrgoTul may be left in place for up to 7 days dependent on wound condition and protocol (when prescribed with a compression bandage system for venous leg ulcers).

Respiratory and Gases Nebuliser Sets Peak Flow Spirometry MIR Spirometers Oxygen Masks Asthma Monitors Oxygen Cylinders Due to the non-adhesive nature of the dressing, Urgotul Absorb is recommended in the treatment of wounds in which the surrounding skin is weakened.

Urgo Medical | UrgoTul

As it includes a super-absorbent layer, the central pad should not be cut. However, the adhesive edges can be cut if necessary using sterile scissors to fit the dressing to different wound shapes. Other Single Use Instruments Curettes Needle Holders Probes Stitch Cutters Skin Staple Removers Proctology More... Parpex P. et al. Management of venous leg ulcers with Cellosorb Micro-adherent dressing: results of a multi-centre clinical trial. Phlebologie 2010; 63: 76-82. Bernard FX, et al. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipidocolloid dressing. J Wound Care. 2005;14(5):215-221 UrgoStart is used in patients with leg ulcers, diabetic foot ulcers and pressure ulcers, from whenever granulation tissue appears until complete healing.Assessment of healing was performed by two blinded observers at each dressing change with weekly photographs taken for later planimetric assessment. Cover UrgoClean with a secondary dressing suitable for the location of the wound and level of exudate.